These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3886683)

  • 21. The use of ultrathin cryosections for localisation of influenza virus antigens in infected vero cell cultures.
    Beesley JE; Campbell DA
    Histochemistry; 1984; 80(5):497-501. PubMed ID: 6480415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-embedding immunolabeling for electron microscopy: an evaluation of permeabilization methods and markers.
    Humbel BM; de Jong MD; Müller WH; Verkleij AJ
    Microsc Res Tech; 1998 Jul; 42(1):43-58. PubMed ID: 9712162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses.
    Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM
    Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
    Gould EA; Buckley A
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1605-8. PubMed ID: 2543793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular localization of rotaviral proteins.
    Richardson SC; Mercer LE; Sonza S; Holmes IH
    Arch Virol; 1986; 88(3-4):251-64. PubMed ID: 3010907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy.
    Carrascosa JL; González P; Carrascosa AL; Garciá-Barreno B; Enjuanes L; Viñuela E
    J Virol; 1986 May; 58(2):377-84. PubMed ID: 3517383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoelectron microscopy of antigen processing in dendritic cells.
    Kleijmeer MJ; Posthuma G; Geuze HJ
    Methods Mol Med; 2001; 64():387-411. PubMed ID: 21374277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of protein A-gold and ferritin immunoelectron microscopy of Semliki Forest virus in mouse brain using a rapid processing technique.
    Evans NR; Webb HE
    J Histochem Cytochem; 1984 Apr; 32(4):372-8. PubMed ID: 6323573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogold and immunogold/silver staining in the ultrastructural localization of target molecules identified by monoclonal antibodies.
    Zelechowska MG; Mandeville R
    Anticancer Res; 1989; 9(1):53-7. PubMed ID: 2705757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal Antibodies and Flaviviruses: a Possible Option?
    Mancini N
    mBio; 2022 Jun; 13(3):e0082422. PubMed ID: 35575500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.
    van der Most RG; Harrington LE; Giuggio V; Mahar PL; Ahmed R
    Virology; 2002 Apr; 296(1):117-24. PubMed ID: 12036323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody competition studies with gold-labelling immunoelectron microscopy.
    Hyatt AD; McPhee DA; White JR
    J Virol Methods; 1988 Jan; 19(1):23-32. PubMed ID: 2450888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and applications of a monoclonal antibody against infectious salmon anaemia virus.
    Falk K; Namork E; Dannevig BH
    Dis Aquat Organ; 1998 Oct; 34(2):77-85. PubMed ID: 9828403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multiple-staining ultrastructural procedure simultaneously detecting three membrane antigens on suspended cells by monoclonal antibodies and pre-embedding immunogold labelling.
    De Panfilis G; Manara GC; Ferrari C; Torresani C; Sansoni P
    Histochem J; 1989 Mar; 21(3):136-44. PubMed ID: 2722559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
    Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.